Chase Knickerbocker
Stock Analyst at Craig-Hallum
(4.95)
# 131
Out of 4,429 analysts
566
Total ratings
57.4%
Success rate
34%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRCE Grace Therapeutics | Reiterated: Buy | $4 | $2.26 | +76.99% | 18 | Jun 22, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | n/a | $3.67 | - | 42 | Jun 17, 2026 | |
| DMAC DiaMedica Therapeutics | Maintained: Buy | n/a | $5.89 | - | 23 | Jun 17, 2026 | |
| ACOG Alpha Cognition | Maintained: Buy | n/a | $6.87 | - | 4 | Jun 17, 2026 | |
| XERS Xeris Biopharma Holdings | Maintained: Buy | n/a | $6.90 | - | 27 | Jun 11, 2026 | |
| CVRX CVRx, Inc. | Maintained: Buy | n/a | $4.86 | - | 27 | Jun 9, 2026 | |
| HROW Harrow | Maintained: Buy | n/a | $42.41 | - | 44 | Jun 8, 2026 | |
| CELC Celcuity | Reiterated: Buy | $189 → $171 | $89.93 | +90.15% | 27 | Jun 3, 2026 | |
| BVS Bioventus | Maintained: Buy | n/a | $8.79 | - | 26 | May 22, 2026 | |
| ETON Eton Pharmaceuticals | Maintained: Buy | n/a | $32.72 | - | 37 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.82 | - | 32 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.436 | - | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.13 | - | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.16 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.86 | - | 27 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.69 | - | 32 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.27 | - | 19 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $11.51 | - | 27 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $9.47 | - | 33 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.01 | - | 15 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1.1 | $1.25 | -12.00% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $75.91 | - | 1 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $174.73 | - | 1 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $96.44 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $58.40 | - | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $262.17 | - | 3 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.68 | - | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.22 | - | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $113.33 | - | 1 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.47 | - | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $9.12 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.07 | n/a | 1 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $38.68 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $14.59 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $17.27 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.32 | n/a | 1 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.37 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $2.52 | n/a | 1 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $17.17 | n/a | 1 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $8.92 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $58 | $30.46 | n/a | 1 | May 3, 2023 |
Grace Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $4
Current: $2.26
Upside: +76.99%
MiMedx Group
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $3.67
Upside: -
DiaMedica Therapeutics
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $5.89
Upside: -
Alpha Cognition
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $6.87
Upside: -
Xeris Biopharma Holdings
Jun 11, 2026
Maintained: Buy
Price Target: n/a
Current: $6.90
Upside: -
CVRx, Inc.
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $4.86
Upside: -
Harrow
Jun 8, 2026
Maintained: Buy
Price Target: n/a
Current: $42.41
Upside: -
Celcuity
Jun 3, 2026
Reiterated: Buy
Price Target: $189 → $171
Current: $89.93
Upside: +90.15%
Bioventus
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $8.79
Upside: -
Eton Pharmaceuticals
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $32.72
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $3.82
Upside: -
May 13, 2026
Maintained: Buy
Price Target: n/a
Current: $0.436
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $5.13
Upside: -
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $7.16
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $3.86
Upside: -
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $10.69
Upside: -
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $7.27
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $11.51
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $9.47
Upside: -
Apr 6, 2026
Maintained: Buy
Price Target: n/a
Current: $14.01
Upside: -
Mar 10, 2026
Rated: Buy
Price Target: $1.1
Current: $1.25
Upside: -12.00%
Nov 20, 2025
Maintained: Buy
Price Target: n/a
Current: $75.91
Upside: -
Nov 19, 2025
Maintained: Buy
Price Target: n/a
Current: $174.73
Upside: -
Oct 20, 2025
Maintained: Buy
Price Target: n/a
Current: $96.44
Upside: -
Oct 17, 2025
Rated: Hold
Price Target: n/a
Current: $58.40
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: n/a
Current: $262.17
Upside: -
Oct 8, 2025
Maintained: Buy
Price Target: n/a
Current: $90.68
Upside: -
Jul 23, 2025
Rated: Hold
Price Target: n/a
Current: $5.22
Upside: -
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $113.33
Upside: -
Jul 14, 2025
Maintained: Buy
Price Target: n/a
Current: $8.47
Upside: -
Feb 26, 2025
Maintained: Buy
Price Target: $12
Current: $9.12
Upside: n/a
Feb 5, 2025
Maintained: Buy
Price Target: n/a
Current: $4.07
Upside: n/a
Aug 28, 2024
Rated: Buy
Price Target: n/a
Current: $38.68
Upside: n/a
Aug 1, 2024
Maintained: Buy
Price Target: $38
Current: $14.59
Upside: n/a
Jul 18, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $17.27
Upside: n/a
Mar 21, 2024
Maintained: Buy
Price Target: $10
Current: $2.32
Upside: n/a
Oct 16, 2023
Rated: Buy
Price Target: n/a
Current: $6.37
Upside: n/a
Sep 13, 2023
Rated: Buy
Price Target: n/a
Current: $2.52
Upside: n/a
Aug 18, 2023
Rated: Buy
Price Target: n/a
Current: $17.17
Upside: n/a
May 4, 2023
Rated: Buy
Price Target: n/a
Current: $8.92
Upside: n/a
May 3, 2023
Rated: Buy
Price Target: $58
Current: $30.46
Upside: n/a